Phenolic anti-inflammatory antioxidant reversal of Aβ-induced cognitive deficits and neuropathology

Neurobiology of Aging

Volumn 22, Issue 6, 2001, Pages 993-1005

  Frautschy, S A ^a   Hu, W ^a   Kim, P ^a   Miller, S A ^a   Chu, T ^a   Harris White, M E ^a   Cole, G M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acquisition; Alzheimer; Antioxidant; Isoprostane; Morris water maze; Neuroinflammation; NSAIDs; Oxidative damage; PSD 95; Synapse; Synaptophysin

Indexed keywords

AMYLOID BETA PROTEIN; CURCUMIN; IBUPROFEN; ISOPROSTANE; SYNAPTOPHYSIN;

ALZHEIMER DISEASE; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG SAFETY; FEMALE; GENOTOXICITY; GLIOSIS; MICROGLIA; NEUROPATHOLOGY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT; SPATIAL MEMORY;

AMYLOID BETA-PROTEIN; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; BRAIN; BRAIN CHEMISTRY; COGNITION DISORDERS; CURCUMIN; DIET; ENZYME-LINKED IMMUNOSORBENT ASSAY; IBUPROFEN; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; INJECTIONS; MAZE LEARNING; MOLECULAR CHAPERONES; NEUROTOXINS; OXIDATION-REDUCTION; PEPTIDE FRAGMENTS; PHENOLS; SENILE PLAQUES; SYNAPTOPHYSIN;

EID: 0035686083     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(01)00300-1     Document Type: Article

References (83)

1. Beta-amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1β and tumor necrosis factor-α (TNFα)-dependent, and involves a TNFα receptor-associated factor- and NFκβ-inducing kinase-dependent signaling mechanism
2. Inflammation and Alzheimer's disease
3. Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition
4. Stereoselective disposition of ibuprofen enantiomers in human cerebrospinal fluid
5. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
6. The free radical theory of aging matures
7. Vitamin E protects nerve cells from amyloid β-protein toxicity
8. Hydrogen peroxide mediates amyloid β protein toxicity
9. Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs
10. In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties
11. Gamma-tocopherol traps mutagenic electrophiles such as NOx and complements alpha-tocopherol: Physiological implications
12. PSD-95 assembles a ternary complex with the N-methyl-D-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain
13. Influence of lipoproteins on microglial degradation of Alzheimer's amyloid beta-protein
14. Microglial contribution to oxidative stress in Alzheimer's disease
15. Inducible nitric-oxide synthase and nitric oxide production in human fetal astrocytes and microglia
16. Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce beta-amyloid fibrils
17. Protease inhibitor co-infusion with amyloid β-protein results in enhanced deposition and toxicity in rat brain
18. Methods for evaluating in vivo rodent models for Alzheimer's disease
19. Rodent models of Alzheimer's disease: Rat Aβ infusion approaches to amyloid deposits
20. Microglial response to amyloid plaques in APPsw transgenic mice
21. Involvement of free oxygen radicals in β-amyloidosis: An hypothesis
22. Apolipoprotein E polymorphism and Alzheimer disease: The Indo-US cross-national dementia study
23. Microglia: Intrinsic immunoeffector cell of the brain
24. Nordihydroguaiaretic acid protects hippocampal neurons against amyloid β-peptide toxicity, and attenuates free radical and calcium accumulation
25. Lipid extraction of tissues with a low-toxicity solvent
26. N-Methyl-D-aspartate receptor antagonist MK-801 and radical scavengers protect cholinergic nucleus basalis neurons against beta-amyloid neurotoxicity
27. Effects of TGFβs(1-3) on Aβ deposition and inflammation and cell-targeting in organotypic hippocampal slice cultures
28. Methods for evaluating a slice culture model of Alzheimer's disease
29. Estrogen and glucocorticoid effects on microglia and Aβ clearance in vitro and in vivo
30. A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: Relevance to Alzheimer disease
31. Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation
32. A beta and perlecan in rat brain: Glial activation, gradual clearance and limited neurotoxicity
33. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease
34. Relationship between oxidative stress and apoE phenotype in Alzheimer's
35. Aβ1-40 but not Aβ1-42 levels in cortex correlate with apolipoprotein E E4 allele dosage in sporadic Alzheimer's disease
36. Modification of microglial reactivity in mAPP/mPS1 transgenic mice using NCX-2216 (nitroflurbiprofen)
37. Microglial tyrosine phosphorylation systems in normal and degenerating brain
38. Influence of retinol deficiency and curcumin/turmeric feeding on tissue microsomal membrane lipid peroxidation and fatty acids in rats
39. Strategy and planning for chemopreventive drug development: Clinical development plan: Curcumin
40. Microglial response to transient focal cerebral ischemia: An immunocytochemical study on the rat cerebral cortex using anti-phosphotyrosine antibody
41. The soluble form of Alzheimer's amyloid beta protein is complexed to high density lipoprotein 3 and very high density lipoprotein in normal human plasma
42. Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins
43. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease
44. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse
45. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease
46. Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia
47. Different amyloidogenic peptides share a similar mechanism of neurotoxicity involving reactive oxygen species and calcium
48. Cyclooxygenase-2 inhibitors: Rationale and therapeutic potential for Alzheimer's disease
49. Activation of microglial cells by beta-amyloid protein and interferon-gamma
50. Enhanced long-term potentiation and impaired learning in mice with mutant postsynaptic density-95 protein
51. Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease
52. The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with ApoE genotype in Alzheimer's disease patients
53. Astroglial expression of human alpha(1)-antichymotrypsin enhances Alzheimer-like pathology in amyloid protein precursor transgenic mice
54. Chronic intracerebroventricular exposure to beta-amyloid(1-40) impairs object recognition but does not affect spontaneous locomotor activity or sensorimotor gating in the rat
55. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline
56. Alpha-1-antichymotrypsin promotes beta-sheet amyloid plaque deposition in a transgenic mouse model of Alzheimer's disease
57. Evidence of oxidative stress and in vivo neurotoxicity of β-amyloid in a transgenic mouse model of Alzheimer's disease
58. A central role for oxidative damage in the pathogenesis and therapeutics of Alzheimer's disease
59. Inhibition of cyclooxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-κβ activation via the NIK/IKK signaling complex
60. Increased 8,12-iso-iPF2alpha-VI in Alzheimer's disease: Correlation of a noninvasive index of lipid peroxidation with disease severity
61. Increased F2-isoprostanes in Alzheimer's disease: Evidence for enhanced lipid peroxidation in vivo
62. Neuroprotective role of curcumin from curcuma longa on ethanol-induced brain damage
63. Effects of environmental enrichment on gene expression in the brain
64. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's disease cooperative study
65. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
66. Amyloid beta-protein and the genetics of Alzheimer's disease
67. Excess brain protein oxidation and enzyme dysfunction in normal aging and Alzheimer disease
68. Amyloid-β deposition is Alzheimer transgenic mice is associated with oxidative stress
69. Widespread peroxynitrite-mediated damage in Alzheimer's disease
70. Nitric oxide scavenging by curcuminoids
71. Risk of Alzheimer's disease and duration of NSAID use
72. N-Methyl-D-asparate receptor subunit proteins and their phosphorylation status are altered selectively in Alzheimer's disease
73. Loss of presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer's disease
74. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment
75. PSD-95 promotes Fyn-mediated tyrosine phosphorylation of the N-methyl-D-aspartate receptor subunit NR2A
76. Systemic administration of the NF-kappab inhibitor curcumin stimulates muscle regeneration after traumatic injury
77. Solvent effects on β-protein toxicity in vivo
78. The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging
79. Lack of long-term effects after β amyloid protein injections in rat brain
80. Curcumin inhibits IL-1 alpha and TNF-alpha induction of AP-1 and NF-kB DNA-binding activity in bone marrow stromal cells
81. Protective effects of idebenone and alpha-tocopherol on beta-amyloid-(1-42)-induced learning and memory deficits in rats: Implication of oxidative stress in beta-amyloid-induced neurotoxicity in vivo
82. Monoclonal antibody to the C-terminus of β-amyloid
83. Scavenging effect of extracts of green tea and natural antioxidants on active oxygen radicals